Cancer Immunology and Immunotherapy:
Taking a Place in Mainstream Oncology
The fields of cancer immunology and immunotherapy continue to make great strides in both providing a comprehensive understanding of the basic mechanisms underlying tumor-immune system interactions and applying this knowledge to the development of effective immune-based cancer therapies. This Keystone Symposia conference is organized to highlight recent insights into the complex roles of immune components and pathways in controlling or alternatively promoting cancer, and to showcase recent uses of cancer vaccines, checkpoint blocking strategies, adoptive cell therapies and cellular engineering approaches, either as mono- or combinatorial therapies, that have resulted in durable, effective and safe therapeutic responses for an increasing number of cancer patients. In addition, this conference focuses on new, developing technologies that are likely to expand our capacity to monitor the effects of cancer immunotherapy with a precision, refinement and at a level that has not been possible in the past. |  |
To view the program of this conference, visit www.keystonesymposia.org/17C7.
Download the meeting summary here.
About Keystone Symposia
Keystone Symposia convenes dynamic, open, peer-reviewed conferences on the exciting new frontiers of life science. Whether you are a geneticist, an immunologist or virtually any other type of life science investigator, and whether you are from academia, industry or the government/nonprofit sector, we think you will find the experience of attending a Keystone Symposia meeting valuable and memorable.
Keystone Symposia on Molecular and Cellular Biology is a 501(c)(3) nonprofit organization with a 45-year history of convening open, peer-reviewed conferences that connect the scientific community and accelerate life science discovery.
Learn more about our 2016-2017 Conference Series
Upcoming Conferences
Upper image of oral squamous cancer cell being attacked by two T cells courtesy of Rita Elena Serda, Duncan Comprehensive Cancer Center at Baylor College of Medicine, and National Cancer Institute, NIH